Core Viewpoint - Analysts forecast that DexCom (DXCM) will report quarterly earnings of $0.65 per share, reflecting a year-over-year increase of 44.4%, with anticipated revenues of $1.25 billion, marking a 12.4% increase compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate for the quarter has been revised 0.2% higher over the last 30 days, indicating a collective reevaluation by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts project 'Revenue- Hardware' to reach $38.01 million, indicating a decrease of 15.5% from the prior-year quarter [5]. - The estimated 'Revenue- Sensor and other' is $1.20 billion, reflecting an increase of 12% from the previous year [5]. - 'Revenue- United States' is expected to be $886.13 million, showing a growth of 10.4% year-over-year [5]. - The average prediction for 'Revenue- International' is $356.26 million, indicating a 14.7% increase from the year-ago quarter [6]. Stock Performance - DexCom shares have experienced a decline of 1.2% over the past month, while the Zacks S&P 500 composite has remained unchanged [6]. - With a Zacks Rank 3 (Hold), DXCM is expected to closely follow overall market performance in the near term [6].